Patents by Inventor Bernt Eric Uhlin

Bernt Eric Uhlin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • VIBRIO CHOLERAE PROTEIN FOR USE AGAINST CANCER
    Publication number: 20240082350
    Abstract: The invention relates to a Vibrio cholerae MakA (motility associated killing factor A) protein for use in therapy, in particular in the treatment or alleviation of cancer such as colorectal cancer. The invention further relates to pharmaceutical compositions comprising a Vibrio cholerae MakA protein as an active ingredient, as well as to methods for treating or alleviating cancer, comprising administering to a subject a therapeutically effective amount a Vibrio cholerae MakA protein.
    Type: Application
    Filed: October 9, 2020
    Publication date: March 14, 2024
    Inventors: Sun Nyunt WAI, Bernt Eric UHLIN, Aftab NADEEM, Karina PERSSON
  • Anti-bodies binding adhesin-derived antigens
    Patent number: 6291649
    Abstract: An antigen which, as its major immunizing component, comprises a determinant of an adhesin polypeptide or an immunogenically active subsequence thereof or a precursor therefor which is convertible to an immunogenically active form, antibodies against which determinant react with the adhesin polypeptide produced by pathogenic adhesin-forming bacteria which adhere to mammalian tissue, antibodies against such antigen, and DNA expressing, as a principal gene product thereof, such antigen.
    Type: Grant
    Filed: May 11, 1998
    Date of Patent: September 18, 2001
    Assignee: Symbicom Aktiebolag
    Inventors: Frederik Carl Lindberg, Björn Olof Lund, Britt Monika B{dot over (a)}ga, Mari Elisabet Norgen, Mikael Göransson, Bernt Eric Uhlin, Jan Staffan Normark, David Lee Lark
  • Vaccines against disease caused by pathogenic pilus-forming bacteria
    Patent number: 5804198
    Abstract: An antigen which, as its major immunizing component, comprises a determinant of an adhesin polypeptide or an immunogenically active subsequence thereof or a precursor therefor which is convertible to an immunogenically active form, antibodies against which determinant react with the adhesin polypeptide produced by pathogenic adhesin-forming bacteria which adhere to mammalian tissue, antibodies against such antigen, and DNA expressing, as a principal gene product thereof, such antigen.
    Type: Grant
    Filed: May 23, 1995
    Date of Patent: September 8, 1998
    Assignee: Symbicom Aktiebolag
    Inventors: Frederik Carl Lindberg, Bjorn Olof Lund, Britt Monika B.ang.ga, Mari Elisabet Norgren, Mikael Goransson, Bernt Eric Uhlin, Jan Staffan Normark, David Lee Lark